Not logged inEfficacy and safety of CAR T-cell therapy in patients with primary or secondary CNS lymphoma: A study on behalf of the EBMT and the GoCART coalition
Saidy, Anna Ossami; Peczynski, Christophe; Thieblemont, Catherine; Daskalakis, Michael; Wehrli, Marc; Beauvais, David; Finke, Juergen; Schorb, Elisabeth; Vandenberghe, Peter; Berning, Philipp; Stelljes, Matthias; Ayuk, Francis; Ram, Ron; Von Bonin, Malte; Dreger, Peter; Bethge, Wolfgang; Kuhnl, Andrea; Jost, Lasse; Stoelzel, Friedrich; von Tresckow, Bastian; Renner, Christoph; Fuhrmann, Stephan; Galimard, Jacques-Emmanuelle; Michel, Eva; Bazarbachi, Ali; Balari, Anna Sureda; Schmitz, Norbert; Glass, Bertram .png)
Share.png)
SaveLong-term outcomes after standard graft-versus-host disease prophylaxis with or without anti-human-T-lymphocyte immunoglobulin in haemopoietic cell transplantation from matched unrelated donors: final results of a randomised controlled trialFinke, Juergen; Schmoor, Claudia; Bethge, Wolfgang Andreas; Ottinger, Hellmut; Stelljes, Matthias; Volin, Liisa; Heim, Dominik; Bertz, Hartmut; Grishina, Olga; Socie, Gerard Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
